Bellevue Life Sciences Acquisition Corp Common Stock
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
EBITDA | -454 | -475 | -450 | |
EBIT | -494 | |||
Net Income | -230 | -97 | -60 | -86 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -226 | -1,416 | -41 | -279 |
Cash | 12 | 119 | 3 | 15 |
Basic Shares | 4,041 | 4,041 | 5,622 | 5,622 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
EBITDA | 944 | -35 | -3 |
EBIT | -1,830 | -35 | -3 |
Net Income | 403 | -35 | -3 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -818 | -4 | |
Cash | 15 | 124 | 4 |
Basic Shares | 5,622 | 9,055 | 7,930 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.05 |
2024-06-30 | -$0.02 |
2024-03-31 | -$0.01 |
2023-12-31 | -$0.01 |
